Canopy Growth and TerrAscend s Arise Bioscience Enter Debt Financing Agreement
News provided by
Share this article
Canopy Growth completes US$20 million loan to Arise Bioscience Inc.
SMITHS FALLS and TORONTO, ON, Dec. 10, 2020 /PRNewswire/ - Canopy Growth Corporation ( Canopy Growth or the Company ) (TSX: WEED) (NASDAQ: CGC) and Arise Bioscience Inc. ( Arise ), a wholly owned subsidiary of TerrAscend Corp. ( TerrAscend ) (CSE: TER) (OTCQX: TRSSF) engaged only in the legal sale of CBD products, today announced they have entered into a loan financing arrangement in the amount of US$20 million (the Loan ) pursuant to a secured debenture (the Debenture ). In connection with the Loan, TerrAscend has issued 2,105,718 common share purchase warrants to the Company (the Warrants ).